11538 Recruiting Trials

Clinical Trials for Cancer

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

Showing 15 of 11538 recruiting trials

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
PHASE3 Mobile, Alabama +4 more NCT06393374
Recruiting
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
NA Kaohsiung, Taiwan NCT07751783
Recruiting
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
N/A Seattle, Washington +4 more NCT01050504
Recruiting
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
NA Brussels +4 more NCT02102165
Recruiting
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
NA Seattle, Washington +4 more NCT04151940
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1 Duarte, California +4 more NCT04221542
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3 Anchorage, Alaska +4 more NCT04267848
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
PHASE2 Birmingham, Alabama +4 more NCT04402788
Recruiting
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
PHASE2 Sacramento, California +4 more NCT04410796
Recruiting
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
PHASE1 Houston, Texas +4 more NCT04715191
Recruiting
Data Collection Study of Pediatric and Adolescent Gynecology Conditions
N/A Bethesda, Maryland +4 more NCT04717349
Recruiting
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
N/A Bethesda, Maryland +4 more NCT04923178
Recruiting
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
PHASE2 Buena Park, California +4 more NCT05198830
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3 Tucson, Arizona +4 more NCT05232916
Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
PHASE1 Duarte, California +4 more NCT05372614
Recruiting
See all 11538 results

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon